Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002372 · ClinicalTrials.gov registry record · Phase 1

A Study of 141W94 in Combination With Other Anti-HIV Drugs

A Phase 1 study of HIV Infections, sponsored by Glaxo Wellcome.

Completed
Registry status
Phase 1
Development phase
48
Enrollment target
3
Study locations

NCT00002372 is a Phase 1 study of HIV Infections that has completed, run by Glaxo Wellcome. The registered enrollment target is 48 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002372, a Phase 1 study of HIV Infections, has completed, sponsored by Glaxo Wellcome.

COMPLETED
Registry status
Phase 1
Development phase
48 participants
Enrollment target
3
Study locations

Study Summary

To determine the steady-state pharmacokinetics of 141W94 in combination with saquinavir, indinavir and nelfinavir after multiple oral dosing. To determine the steady-state pharmacokinetics of saquinavir, indinavir, and nelfinavir in combination with 141W94 after multiple oral dosing. To assess the safety and tolerability of multiple doses of 141W94 when combined with saquinavir, indinavir and nelfinavir.

Conditions Studied

HIV Infections

Interventions

  • DRUG Indinavir sulfate
  • DRUG Nelfinavir mesylate
  • DRUG Saquinavir
  • DRUG Amprenavir

Study Locations (3)

California

  • Univ of California / San Diego Treatment Ctr - San Diego
  • ViRx Inc - San Francisco

North Carolina

  • Univ of North Carolina at Chapel Hill / Duke Univ Med Ctr - Durham

Trial Details

FieldValue
Enrollment Target 48 participants
Phase Phase 1

Sponsor

Glaxo Wellcome

65 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002372

The ClinicalTrials.gov registry entry for NCT00002372 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (89% lower). The listed sponsor is Glaxo Wellcome, which has 65 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 4 interventions - of which Indinavir sulfate is the first listed.

NCT00002372 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00002372 about?

NCT00002372 is a clinical study titled "A Study of 141W94 in Combination With Other Anti-HIV Drugs". To determine the steady-state pharmacokinetics of 141W94 in combination with saquinavir, indinavir and nelfinavir after multiple oral dosing. To determine the steady-state pharmacokinetics of saquinavir, indinavir, and nelfinavir in combination with 141W94 after multiple oral dosing. To assess the s...

What is the current status of trial NCT00002372?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants.

What conditions does trial NCT00002372 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00002372?

The interventions under investigation include: Indinavir sulfate (DRUG), Nelfinavir mesylate (DRUG), Saquinavir (DRUG), Amprenavir (DRUG).

Who is sponsoring clinical trial NCT00002372?

This trial is sponsored by Glaxo Wellcome, which has 65 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002372 being conducted?

This trial has 3 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.